Endometrial stromal sarcoma - Observational evidence of a genetic background?

European Journal of Gynaecological Oncology

Volumn 26, Issue 3, 2005, Pages 288-290

  Reich, O ^a   Regauer, S ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Familial cancer; Genetic polymorphism; Genetic predisposition; Hormone sensitive tumors

Indexed keywords

HORMONE;

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CLINICAL OBSERVATION; ENDOMETRIUM CANCER; ENDOMETRIUM SARCOMA; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; HUMAN; INTERNET; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; PROSTATE CARCINOMA; QUESTIONNAIRE; THYROID CANCER;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SARCOMA, ENDOMETRIAL STROMAL;

EID: 21044450047     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chu M.C., Mor G., Lim C., Zheng W., Parkash V., Schwartz P.E.: "Low-grade endometrial stromal sarcoma: hormonal aspects". Gynecol. Oncol., 2003, 90, 170.
2. Reich O., Regauer S., Urdl M., Lahousen M., Winter R.: "Estrogen and progesterone receptor content in low-grade-stromal sarcomas". Br. J. Cancer, 2000, 82, 1030.
3. Beer T.W., Buchanan R., Buckley C.H.: "Uterine stromal sarcoma following tamoxifen-treatment". J. Clin. Pathol., 1995, 48, 596.
4. Martin-Loeches M., Rius J., Orti R.M.: "Uterine sarcoma associated with tamoxifen use: case report". Eur. J. Gynecol. Oncol., 2003, 24, 202.
5. Chang K.L., Crabtree G.S., Lim-Tan S.K., Kempson R.L., Hendrickson M.R.: "Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases". Am. J. Surg. Pathol., 1990, 14, 415.
6. Walton L.A., Siegfried J.M., Nelson K.G., Siegal G., Kaufman D.G.: "Endometrial stromal cells in culture: an attempt to understand the genesis of biologic activity of uterine sarcomas". Gynecol. Oncol., 1986, 24, 247.
7. Hendrickson M.R., Tavassoli F.A., Kempson R.L., McCluggage W.G., Haller U., Kubik-Huch R.A.: "Mesenchymal tumours and related lesions". In: Tavassoli F.A. (ed.), Tumors of the Breast and Female Genital Organs. WHO, Lyon, France, IARC Press, 2003, 233.
8. Reich O., Regauer S.: "Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study". Mod. Path., 2004, 17, 104.
9. Goldgar D., Stratton M.R.: "Familial aggregation of cancers of the breast and female genital organs". In: Tavassoli F.A. (ed.), Tumors of the Breast and Female Genital Organs, WHO, Lyon, France, IARC Press, 2003, 336.
10. Briand P., Hou-Jensen K., Thorpe S.M., Rose C.: "Hormone dependent uterine sarcomas in GR mice". Eur. J. Cancer, 1981, 17, 635.
11. Ellis I.O., Schnitt S.J., Sastre-Garau X., Bussolati G., Tavassoli F.A., Eusebi V., Peterse J.L. et al.: "Invasive breast carcinoma". In: F.A. Tavassoli (ed.), Tumors of the Breast and Female Genital Organs, WHO, Lyon, France, 2003, 13.
12. Press M.F., Scully R.E.: "Endometrial 'sarcomas' complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy". Gynecol. Oncol., 1985, 21, 135.
13. Miyoshi Y., Ando A., Hasegawa S., Ishitobi M., Yamamura J., Irahara N. et al.: "Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk". Eur J Cancer, 2003, 39, 2531.
14. Suzuki K., Nakazato H., Matsui H., Koike H., Okugi H., Kashiwagi B. et al.: "Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population". Cancer, 2003, 98, 1411.
15. Berstein L.M., Imyanitov E.N., Kovalevskij A.J., Maximov S.J., Vasilyev D.A., Buslov K.G. et al.: "CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity". Cancer Lett., 2004, 207, 191.